A single systemic injection of AAV9-hIGFBP2 prevents left ventricular hypertrophy and dysfunction in metabolic syndrome
29 April 2017 (00:00 - 00:00)
Organised by:
About the speaker

Rangueil Hospital of Toulouse, Toulouse (France)
8 More presentations in this session
Miss L. Zhang (Luxembourg, LU)
Miss A. Voronova (Moscow, RU)
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April - 2 May 2017
